IN BRIEF: Angle names Peter Collins as interim CEO

Related news

Angle PLC - Guildford, England-based liquid biopsy company, which is to be renamed CelLBxHealth PLC - Appoints Peter Collins as interim chief executive officer and Klaas de Boer as a senior advisor to the board. Last month, Andrew Newland stepped down as CEO following talks with an unnamed ‘significant shareholder’. Notes Collins’ over 25 years of experience in oncology and diagnostics development.

‘Peter is an exceptional leader with a proven track record of commercial excellence, disciplined execution, and innovation. The board is delighted that he has agreed to serve as interim CEO while we continue the process to make a permanent appointment. We are also delighted to have Klaas assisting the board and management team during the coming period,’ says Executive Chair Jan Groen.

Current stock price: 1.75 pence, down 7.9% on Thursday afternoon in London.

12-month change: down 77%

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Directors

Ways to help you invest your money

Our investment accounts

Put your money to work with our range of investment accounts. Choose from ISAs, pensions, and more.

Need some investment ideas?

Let us give you a hand choosing investments. From managed funds to favourite picks, we’re here to help.

Read our expert tips and insights

Our investment experts share their knowledge on how to keep your money working hard across the markets.